Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf

Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01562665

Acronym

Lung-EPICLIN/G

Enrollment

Registered

2012-03-26

Start date

2012-06-30

Completion date

2015-02-28

Last updated

2016-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Small Cells Lung Cancer

Keywords

All patients with NSCLC attending participating hospitals

Brief summary

The overall aim of the study is: To provide accurate and reliable information regarding NSCLC clinical management across MENA region in order to detect unmet medical needs of this disease in terms of: * Patient and hospital characteristics. * Diagnostic and treatment approaches: initial and subsequent. * Follow-up patterns in clinical management. * Outcomes: symptoms, death, functionality, quality of life. * Use of resources and burden on patients and health care systems.

Detailed description

Epidemiological study to describe NSCLC clinical management patterns in MENA

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women, attending the responsible department of treating this type of patients for the first time between November 1st, 2011 and August 30th, 2012 For PRO * Sub-sample: * ability to read and write since they will be asked to participate in the PRO part of the study. * Selection will not be based on the disease stage of each patient, in order to avoid a selection bias.

Exclusion criteria

* According to the study design there will not be any

Design outcomes

Primary

Measure	Time frame
Use of health resources by collecting data about hospital description and characteristics, Disease Diagnosis Procedures and Therapy information	April 2014(26 Months)

Secondary

Measure	Time frame
Patient-Reported Outcomes (PRO) through self-administered questionnaires and the patients will be asked to complete them at each evaluation visit(25% of the whole sample)	April 2014(26 Months)

Countries

Bahrain, Qatar, United Arab Emirates

Outcome results